Zentiva Romania’s objectives for the next decade envisage expanding production at the two plants it owns in Bucharest and adding new products to its portfolio.
Drugmaker Zentiva (SCD) posted RON124 million net profit in the first nine months of 2023, compared with RON33.6 million in the same period last year, while revenue rose to RON684 million from RON538 million.